not a good read, page-2

When compared to most of the commentaries that I have read on Chris' blog so far it is a bloody good read Nadalol actually gets a couple of browny points from Chris! Saw no reference in his commentary to the inhaled form of nadalol that is currently under development though. This is more than just another off-label use of nadalol and I reckon that this where the big dollars might be down the track. Tend to agree with Chris that the other two agents that IVX are playing around with might be better off in the wpb, although happy to be proved wrong here.